CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 25 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -33.3% | 481 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 481 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 481 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 481 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 481 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | +33.3% | 481 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | -75.0% | 481 | -75.0% | 0.00% | – |
| Q2 2017 | $12,000 | +20.0% | 1,922 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | -23.1% | 1,922 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | -7.1% | 1,922 | 0.0% | 0.00% | – |
| Q3 2016 | $14,000 | -12.5% | 1,922 | 0.0% | 0.00% | – |
| Q2 2016 | $16,000 | +100.0% | 1,922 | +33.3% | 0.00% | – |
| Q1 2016 | $8,000 | 0.0% | 1,442 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | +33.3% | 1,442 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -14.3% | 1,442 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | +16.7% | 1,442 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 1,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,006,667 | $16,053,000 | 2.62% |
| ARS Investment Partners, LLC | 860,002 | $6,880,000 | 0.84% |
| Gagnon Advisors, LLC | 129,573 | $1,037,000 | 0.77% |
| GAGNON SECURITIES LLC | 201,698 | $1,614,000 | 0.58% |
| PERKINS CAPITAL MANAGEMENT INC | 74,500 | $596,000 | 0.54% |
| Benchmark Capital Advisors | 75,092 | $601,000 | 0.48% |
| Cortina Asset Management, LLC | 524,388 | $4,195,000 | 0.21% |
| Whitegate Investment Counselors, Inc. | 11,000 | $88,000 | 0.02% |
| Phocas Financial Corp. | 20,000 | $160,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 215,353 | $1,723,000 | 0.01% |